Travere Therapeutics (TVTX) Stock Research

Travere Therapeutics

· TVTX

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

5.655 B

-1.85%

Thursday

Travere Therapeutics price target raised by $14 at Guggenheim, here's why

TVTX

Sep 24, 7:18 AM

Over a week ago

Travere Therapeutics receives notice of allowance for FILSPARI patent

TVTX

Sep 23, 7:09 AM

Travere Therapeutics CEO Dube to step down

TVTX

Sep 21, 4:06 PM

Travere Therapeutics price target raised by $19 at Piper Sandler, here's why

TVTX

Aug 17, 7:05 AM

Travere Therapeutics price target raised by $10 at Evercore ISI

TVTX

Aug 10, 8:16 AM

Travere Therapeutics price target raised by $14 at Wedbush, here's why

TVTX

Aug 6, 8:46 AM

Travere Therapeutics price target raised by $8 at Canaccord, here's why

TVTX

Aug 6, 7:06 AM

Travere Therapeutics price target raised by $15 at TD Cowen, here's why

TVTX

Aug 5, 9:12 AM

Travere Therapeutics price target raised by $8 at Evercore ISI

TVTX

Aug 5, 8:13 AM

Travere Therapeutics price target raised by $10 at Guggenheim, here's why

TVTX

Aug 5, 7:24 AM

Travere Therapeutics price target raised by $19 at Stifel

TVTX

Aug 5, 7:10 AM

Travere Therapeutics price target raised by $15 at Citi, here's why

TVTX

Aug 5, 6:26 AM

Closing Bell Movers: SpaceX slips after first quarterly report as public company

+16

Aug 4, 6:11 PM

Travere Therapeutics reports Q2 adjusted EPS (10c), consensus (14c)

TVTX

Aug 4, 4:04 PM

Travere Therapeutics price target raised by $6 at Canaccord, here's why

TVTX

Jul 30, 7:15 AM

Travere Therapeutics price target raised by $5 at BofA, here's why

TVTX

Jul 22, 9:03 AM

Travere Therapeutics price target raised by $9 at Guggenheim, here's why

TVTX

Jun 25, 7:29 AM

Travere Therapeutics price target raised by $6 at Wedbush, here's why

TVTX

Jun 22, 8:18 AM

Travere Therapeutics announces retirement of Chief Research Officer in 2027

TVTX

Jun 16, 4:31 PM

Travere Therapeutics price target raised by $8 at Citi, here's why

TVTX

Jun 15, 6:16 AM

Travere Therapeutics says Filspari generally well tolerated in Phase 3 study

TVTX

Jun 4, 10:11 AM

Travere Therapeutics price target raised by $3 at Citi, here's why

TVTX

Jun 3, 1:01 PM

Travere Therapeutics price target raised by $10 at H.C. Wainwright, here's why

TVTX

Jun 2, 11:29 AM

Travere Therapeutics enters into exclusive licensing agreement with Everest

TVTX

Jun 2, 7:05 AM

Travere confirms Notice of Allowance from USPTO for Filspari patent application

TVTX

May 28, 9:24 AM

Charts